Toggle navigation
Home
Search
Services
Blog
Contact
About
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W.
Fox Chase Cancer Center, Philadelphia, PA, United States
Search 141 grants from Steven Johnson
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PPARgamma as an architectural regulator of gene expression in endocrine signaling
Research Training in Renal Diseases
Functional Analysis of Mammalian Histone Deacetylases
Children at Risk for Depression
NSF Postdoctoral Fellowship in Biology FY 2011
Recently added grants:
Identify the host genetic determinants of immune response and TB countrol
Measure the metabolic and genetic factors that determine M. Tuberculosis
Forum on Microbial Threats
Functional analysis of a Group A streptococcal locus important for fitness in soft tissue
Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA009301-02
Application #
2085238
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1993-03-02
Project End
Budget Start
1993-03-02
Budget End
1994-01-01
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Related projects
NIH 1993
F32 CA
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W. / Fox Chase Cancer Center
NIH 1992
F32 CA
DNA Repair and Cisplatin Resistance in Ovarian Cancer
Johnson, Steven W. / Fox Chase Cancer Center
Publications
Johnson, S W; Swiggard, P A; Handel, L M et al.
(1994)
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
Cancer Res 54:5911-6
Comments
Be the first to comment on Steven Johnson's grant